U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898320) titled 'Cardiac Injury Due to Anthracycline in Paediatric Oncological Patients' on March 20.
Brief Summary: The study investigates the role of echocardiography and of serum biomarkers (NT-proBNP, cardiac Troponin-I) in predicting cardiac injury in a cohort of paediatric oncological patients treated with Anthracycline chemotherapy.
Study Start Date: July 21, 2023
Study Type: OBSERVATIONAL
Condition:
Heart Injuries
Anthracycline
Recruitment Status: RECRUITING
Sponsor: IRCCS Burlo Garofolo
Published by HT Digital Content Services with permission from Health Daily Digest....